Claire Alderton

426 total citations
8 papers, 347 citations indexed

About

Claire Alderton is a scholar working on Molecular Biology, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Claire Alderton has authored 8 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Physiology and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Claire Alderton's work include Peroxisome Proliferator-Activated Receptors (2 papers), Nutrition and Health in Aging (2 papers) and Biochemical Acid Research Studies (2 papers). Claire Alderton is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (2 papers), Nutrition and Health in Aging (2 papers) and Biochemical Acid Research Studies (2 papers). Claire Alderton collaborates with scholars based in United Kingdom, United States and Estonia. Claire Alderton's co-authors include Marina Zvartau‐Hind, Gary E. Landreth, Suzanne Craft, Ann M. Saunders, Ülla Linnamägi, Michael Gold, Sharon Sawchak, Michael C. Irizarry, R. L. Davis and Alan M. Rapoport and has published in prestigious journals such as Neurology, International Journal of Behavioral Nutrition and Physical Activity and BMC Health Services Research.

In The Last Decade

Claire Alderton

7 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claire Alderton United Kingdom 5 232 104 77 74 69 8 347
Anastazija Gnjec Australia 6 308 1.3× 186 1.8× 62 0.8× 65 0.9× 49 0.7× 7 502
Devon Gessert United States 5 261 1.1× 90 0.9× 83 1.1× 73 1.0× 102 1.5× 9 467
Valérie Leduc Canada 10 175 0.8× 124 1.2× 62 0.8× 42 0.6× 48 0.7× 13 421
Jana Povová Czechia 7 150 0.6× 113 1.1× 43 0.6× 51 0.7× 62 0.9× 10 335
James W. Kupiec United States 7 264 1.1× 69 0.7× 67 0.9× 146 2.0× 87 1.3× 20 451
Jorge A. Serra Argentina 13 227 1.0× 106 1.0× 53 0.7× 57 0.8× 108 1.6× 19 473
Karen Campbell United States 4 218 0.9× 52 0.5× 73 0.9× 96 1.3× 124 1.8× 5 407
Conn Harrington United States 5 133 0.6× 81 0.8× 33 0.4× 60 0.8× 47 0.7× 10 266
Malin Degerman-Gunnarsson Sweden 11 447 1.9× 194 1.9× 130 1.7× 67 0.9× 137 2.0× 12 714

Countries citing papers authored by Claire Alderton

Since Specialization
Citations

This map shows the geographic impact of Claire Alderton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Alderton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Alderton more than expected).

Fields of papers citing papers by Claire Alderton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Alderton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Alderton. The network helps show where Claire Alderton may publish in the future.

Co-authorship network of co-authors of Claire Alderton

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Alderton. A scholar is included among the top collaborators of Claire Alderton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Alderton. Claire Alderton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
2.
3.
Gold, Michael, Claire Alderton, Marina Zvartau‐Hind, et al.. (2010). Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study. Dementia and Geriatric Cognitive Disorders. 30(2). 131–146. 287 indexed citations
4.
Gold, Michael, Claire Alderton, Marina Zvartau‐Hind, et al.. (2009). O1‐04‐06: Effects of rosiglitazone as monotherapy in APOE4‐stratified subjects with mild‐to‐moderate Alzheimer's disease. Alzheimer s & Dementia. 5(4S_Part_3). 15 indexed citations
5.
Zvartau‐Hind, Marina, Claire Alderton, Ann M. Saunders, et al.. (2009). P1‐245: Safety and tolerability of rosiglitazone XR in a randomised, placebo‐controlled study in APOE4‐stratified subjects with mild‐to‐moderate Alzheimer's disease. Alzheimer s & Dementia. 5(4S_Part_8). 1 indexed citations
6.
Alderton, Claire, Marina Zvartau‐Hind, Ann M. Saunders, et al.. (2009). P1‐263: Secondary endpoint and responder analyses in a study of rosiglitazone XR in APOE4‐stratified subjects with mild‐to‐moderate Alzheimer's disease. Alzheimer s & Dementia. 5(4S_Part_8). 8 indexed citations
7.
Leuténegger, M, Luigi Saccà, Claire Alderton, D.J.A. Eckland, & Sally Lettis. (1997). Double-masked, placebo-controlled, dose-ranging study of troglitazone 10 to 200 mg once daily in non—insulin-dependent diabetes mellitus. Current Therapeutic Research. 58(7). 403–416. 8 indexed citations
8.
Rapoport, Alan M., W. Hester Visser, N.R. Cutler, et al.. (1995). Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptan. Neurology. 45(8). 1505–1509. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anastazija Gnjec Breakdown of academic impact, for papers by Devon Gessert Breakdown of academic impact, for papers by Valérie Leduc Breakdown of academic impact, for papers by Jana Povová Breakdown of academic impact, for papers by James W. Kupiec Breakdown of academic impact, for papers by Jorge A. Serra Breakdown of academic impact, for papers by Karen Campbell Breakdown of academic impact, for papers by Conn Harrington Breakdown of academic impact, for papers by Malin Degerman-Gunnarsson
Rankless by CCL
2026